Breaking News
Get 40% Off 0
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now
Close

Hisamitsu Pharmaceutical Inc (4530)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
3,740.0 -79.0    -2.07%
02/05 - Closed. Currency in JPY ( Disclaimer )
  • Volume: 323,000
  • Bid/Ask: 3,728.0 / 3,741.0
  • Day's Range: 3,729.0 - 3,858.0
Type:  Equity
Market:  Japan
ISIN:  JP3784600003 
Hisamitsu Pharmaceutical Inc 3,740.0 -79.0 -2.07%

4530 Balance Sheet

 
Featured here, the Balance Sheet for Hisamitsu Pharmaceutical Inc, which summarizes the company's financial position including assets, liabilities and shareholder equity for each of the latest 4 period ending dates (either quarterly or annually).
AnnualQuarterly
InvestingPro Advanced Balance Sheet
Period Ending: 2024
29/02
2023
30/11
2023
31/08
2023
31/05
Total Current Assets 194022 200181 214909 201375
Cash and Short Term Investments 125321 123912 141429 136520
Cash - - - -
Cash & Equivalents 112459 111141 127043 122303
Short Term Investments - 12771 14386 14217
Total Receivables, Net - 42109 41679 38542
Accounts Receivables - Trade, Net - 42109 41679 38542
Total Inventory - 21606 20547 20048
Prepaid Expenses - - - -
Other Current Assets, Total 4542 12554 11254 6265
Total Assets - 334909 - 320184
Property/Plant/Equipment, Total - Net - 51025 - 45196
Property/Plant/Equipment, Total - Gross - - - -
Accumulated Depreciation, Total - - - -
Goodwill, Net - 4649 - -
Intangibles, Net 5387 915 925 877
Long Term Investments 76813 67616 67007 72734
Note Receivable - Long Term - - - -
Other Long Term Assets, Total - 10523 - 2
Other Assets, Total -2754 4822 4507 1988
Total Current Liabilities 45938 50346 - 44996
Accounts Payable 16263 10052 - 13987
Payable/Accrued - - - -
Accrued Expenses 1831 678 1252 369
Notes Payable/Short Term Debt 1071 1071 1071 1071
Current Port. of LT Debt/Capital Leases - - - -
Other Current liabilities, Total 26423 32230 41950 29569
Total Liabilities - 63414 69197 58556
Total Long Term Debt 679 95 112 131
Long Term Debt 76 95 112 131
Capital Lease Obligations - - - -
Deferred Income Tax - - - -
Minority Interest - 2410 2296 2220
Other Liabilities, Total 7289 8290 11524 8936
Total Equity 267079 271492 275103 261628
Redeemable Preferred Stock, Total - - - -
Preferred Stock - Non Redeemable, Net - - - -
Common Stock, Total - 8473 8473 8473
Additional Paid-In Capital - 2361 2361 2361
Retained Earnings (Accumulated Deficit) 242578 241100 - 236333
Treasury Stock - Common - -35341 -28533 -27196
ESOP Debt Guarantee - - - -
Unrealized Gain (Loss) - - - -
Other Equity, Total 50660 54899 52100 41657
Total Liabilities & Shareholders' Equity 328779 334909 344300 320184
Total Common Shares Outstanding - 76.11 77.47 77.74
Total Preferred Shares Outstanding - - - -
* In Millions of JPY (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on the balance sheet, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

4530 Comments

Write your thoughts about Hisamitsu Pharmaceutical Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email